N ɛ -acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors.
Ontology highlight
ABSTRACT: HDAC inhibitors have been developed very rapidly in clinical trials and even in approvals for treating several cancers. However, there are few reported HDAC inhibitors designed from N ɛ -acetyl lysine. In the current study, we raised a novel design, which concerns N ɛ -acetyl lysine derivatives containing amide acetyl groups with the hybridization of ZBG groups as novel HDAC inhibitors.
SUBMITTER: Wang F
PROVIDER: S-EPMC6599804 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA